These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16455607)
1. In vitro and in vivo release of naltrexone from biodegradable depot systems. Liu Y; Sunderland VB; O'Neil AG Drug Dev Ind Pharm; 2006 Jan; 32(1):85-94. PubMed ID: 16455607 [TBL] [Abstract][Full Text] [Related]
2. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment. Pagar KP; Vavia PR Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187 [TBL] [Abstract][Full Text] [Related]
3. Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres. Akala EO; Wiriyacoonkasem P; Pan G Drug Dev Ind Pharm; 2011 Jun; 37(6):673-84. PubMed ID: 21449706 [TBL] [Abstract][Full Text] [Related]
4. Preparation of biodegradable microspheres and matrix devices containing naltrexone. Dinarvand R; Moghadam SH; Mohammadyari-Fard L; Atyabi F AAPS PharmSciTech; 2003; 4(3):E34. PubMed ID: 14621966 [TBL] [Abstract][Full Text] [Related]
5. Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation. Sun L; Wang T; Gao L; Quan D; Feng D Pharm Dev Technol; 2013; 18(4):828-33. PubMed ID: 22759074 [TBL] [Abstract][Full Text] [Related]
6. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. Blanco-PrĂeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
8. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Freitas MN; Marchetti JM Int J Pharm; 2005 May; 295(1-2):201-11. PubMed ID: 15848005 [TBL] [Abstract][Full Text] [Related]
9. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531 [TBL] [Abstract][Full Text] [Related]
11. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies. Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213 [TBL] [Abstract][Full Text] [Related]
12. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348 [TBL] [Abstract][Full Text] [Related]
13. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers. Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156 [TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres. Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379 [TBL] [Abstract][Full Text] [Related]
15. Development, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres as a depot system for parenteral delivery. Sinha VR; Trehan A Drug Deliv; 2008 Aug; 15(6):365-72. PubMed ID: 18686080 [TBL] [Abstract][Full Text] [Related]
16. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice. He GA; Hou HM; Liu XJ Acta Pharmacol Sin; 2001 Jun; 22(6):530-3. PubMed ID: 11747760 [TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro and in vivo release characteristics of sustained release ofloxacin microspheres. Abazinge M; Jackson T; Yang Q; Owusu-Ababio G Drug Deliv; 2000; 7(2):77-81. PubMed ID: 10892407 [TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release. Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method. Yamakawa I; Tsushima Y; Machida R; Watanabe S J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728 [TBL] [Abstract][Full Text] [Related]
20. Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation. Guan Q; Chen W; Hu X Drug Des Devel Ther; 2015; 9():791-8. PubMed ID: 25709403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]